“Isagenix’s cash on hand of $19 million as of June 2022 is insufficient to repay the $29 million of revolver borrowings and term loan amortization of $18.8 million over the next 12 months”
“Isagenix’s governance risk is negative and reflects an aggressive financial policy as evidenced by high financial leverage, unsustainable capital structure and continued deterioration of operations.”
According to a short Isagenix press release:
Isagenix International (“Isagenix” or “the Company”), a leader in providing nutrition solutions for weight loss, performance, and healthy aging, announced today that it has entered into a forbearance agreement with an ad hoc group of the Company’s secured lenders.
This forbearance agreement is an important first step as the Company works toward a holistic solution for its secured debt on terms that will ensure Isagenix’s continued market leadership and long-term growth. Isagenix is focused on operating business as usual — both during the forbearance period and well into the future.
“We are excited to have the enthusiastic support and continued partnership of our investors as we look ahead to the future and longevity of Isagenix,”
said Isagenix Chief Executive Officer Sharron Walsh.
“We are collaborating to create a stronger financial foundation for our business, which will further enable us to invest in

Read more...